InChi Code: InChI=1S/C12H19N3O7S/c1-6(16)23-5-8(11(20)14-4-10(18)19)15-9(17)3-2-7(13)12(21)22/h7-8H,2-5,13H2,1H3,(H,14,20)(H,15,17)(H,18,19)(H,21,22)/t7-,8-/m0/s1
If symptoms improved and markers trended down, continue at current dose
What does the evidence currently show Data from randomized controlled trials (RCTs) and meta-analysis of RCTs show that semaglutide and tirzepatide (two types of GLP-1 medications) reduce body weight, waist circumference, and improve major cardiometabolic risk biomarkers (e.g
This can involve maintaining proper levels of essential nutrients such as thiamine (Vitamin B1), which plays a vital role in energy metabolism and nervous system functioning
Even a modest weight reduction can provide relief for conditions like sleep apnea, sometimes eliminating the need for bulky breathing devices used to treat it